III.J.24. Medical Countermeasures for Staphylococcal Enterotoxin B (SEB). Develop medical countermeasures against the biological warfare threat of SEB toxin. By FY96, transition to advanced development a vaccine which will prevent 80 percent of the immunized animals from death against a lethal aerosol challenge of SEB (milestone 1 transition). By FY96, demonstrate the feasibility of producing a secondary generation vaccine which will protect 90 percent of the immunized animals against both a lethal and incapacitating aerosol challenge of SEB (Milestone 0 transition). By FY00, transition to advanced development the second generation vaccine (Milestone 1 transition).
Supports: Army Modernization Plan, Medical Annex OProject, Sustain, and Protect the Force by Development of NBC Agent Preventive Measures. Provides for the exploration, demonstration, and validation of biological defense vaccines as outlined by the DEPSECDEF (26 Aug 91) and the Joint Requirements Oversight Council (31 Aug 92).
|STO Manager:||TSO:||TRADOC POC:|
|Dr. Anna Johnson-Winegar||MAJ Mark Seymour||CPT Ensor|